Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07366060 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness of Third Occipital Nerve Pulsed Radiofrequency in Cervicogenic Headache

Study acronym: TON-PRF-CH
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 26, 2026 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
Cervicogenic headache is a secondary headache disorder originating from cervical spine structures and is frequently associated with chronic pain, functional limitation, and impaired quality of life. The third occipital nerve, which innervates the C2-3 zygapophyseal joint, plays an important role in the pathophysiology of cervicogenic headache. Pulsed radiofrequency is a minimally invasive interventional pain management technique that modulates nociceptive transmission without causing permanent neural damage. Although third occipital nerve pulsed radiofrequency is increasingly used in clinical practice, prospective data evaluating its clinical effectiveness and safety remain limited. The aim of this prospective, single-center study is to evaluate the effectiveness and safety of ultrasound-guided third occipital nerve pulsed radiofrequency treatment in patients diagnosed with cervicogenic headache. Pain intensity, headache characteristics, analgesic consumption, and patient-reported outcomes will be assessed before treatment and during follow-up. The results of this study are expected to contribute to clinical evidence supporting interventional treatment strategies for cervicogenic headache.
Trial Details
NCT Number NCT07366060
Lead Sponsor Ankara City Hospital Bilkent
Conditions
(from sponsor)
Cervicogenic Headache, Third Occipital Nerve
Related terms Post-Traumatic Headache
Enrollment 25 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov